Received Aug 2, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | 3 | W014513 | — |
No additional AE/No PQC.; Pharmacist calling to inquire about revaccination. Pharmacist reports a patient received an expired dose of GARDASIL 9 on 28JUL2025. Pharmacist reports the GARDASIL 9 expired on 26JAN2025 and no temperature excursion ever occurred. Pharmacist did inf; This spontaneous report was received from a/an Pharmacist and refers to a(n) patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 28-Jul-2025, the patient started therapy with Human Papillomavirus 9-valent Vaccine, Recombinant (lot #W014513, expiration date: 26-Jan-2025), dose number 3, (3rd dose (last dose)),. On an unknown date, the patient started therapy with unknown dosage. The patient started therapy with for the treatment of prophylaxis. The patient started therapy with Human Papillomavirus 9-valent Vaccine, Recombinant for the treatment of prophylaxis. On 28-Jul-2025, the patient experienced Pharmacist calling to inquire about revaccination. Pharmacist reports a patient received an expired dose of GARDASIL 9 on 28JUL2025. Pharmacist reports the GARDASIL 9 expired on 26JAN2025 and no temperature excursion ever occurred. Pharmacist did inf. On an unknown date, the patient experienced No additional AE/No PQC. Lot # is being requested and will be submitted if received.